| Year |
Citation |
Score |
| 2023 |
Lumley LA, Nguyen DA, de Araujo Furtado M, Niquet J, Linz E, Schultz CR, Stone MF, Wasterlain CG. Efficacy of lacosamide and rufinamide as adjuncts to midazolam-ketamine treatment against cholinergic-induced status epilepticus in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 37977809 DOI: 10.1124/jpet.123.001789 |
0.329 |
|
| 2023 |
Nguyen D, Stone MF, Schultz CR, de Araujo Furtado M, Niquet J, Wasterlain CG, Lumley LA. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 37770198 DOI: 10.1124/jpet.123.001784 |
0.306 |
|
| 2023 |
Suchomelova L, Thompson KW, Baldwin RA, Niquet J, Wasterlain CG. Interictal aggression in rats with chronic seizures after an early life episode of status epilepticus. Epilepsia Open. PMID 36939640 DOI: 10.1002/epi4.12734 |
0.306 |
|
| 2023 |
Wasterlain C. Fifty years of research on status epilepticus: Seizures use hippocampal memory circuits to generate status epilepticus and disrupt brain development. Epilepsy & Behavior : E&B. 141: 109142. PMID 36907081 DOI: 10.1016/j.yebeh.2023.109142 |
0.339 |
|
| 2018 |
Thompson KW, Suchomelova L, Wasterlain CG. Treatment of early life status epilepticus: What can we learn from animal models? Epilepsia Open. 3: 169-179. PMID 30564776 DOI: 10.1002/epi4.12271 |
0.306 |
|
| 2017 |
Dingledine R, Coulter DA, Fritsch B, Gorter JA, Lelutiu N, McNamara J, Nadler JV, Pitkänen A, Rogawski MA, Skene P, Sloviter RS, Wang Y, Wadman WJ, Wasterlain C, Roopra A. Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Scientific Data. 4: 170061. PMID 28485718 DOI: 10.1038/Sdata.2017.61 |
0.341 |
|
| 2010 |
Lu X, Roberts E, Xia F, Sanchez-Alavez M, Liu T, Baldwin R, Wu S, Chang J, Wasterlain CG, Bartfai T. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proceedings of the National Academy of Sciences of the United States of America. 107: 15229-34. PMID 20660766 DOI: 10.1073/Pnas.1008986107 |
0.337 |
|
| 2006 |
Pereira de Vasconcelos A, Riban V, Wasterlain C, Nehlig A. Role of endothelial nitric oxide synthase in cerebral blood flow changes during kainate seizures: a genetic approach using knockout mice. Neurobiology of Disease. 23: 219-27. PMID 16690320 DOI: 10.1016/J.Nbd.2006.03.002 |
0.327 |
|
| 2005 |
de Vasconcelos AP, Bouilleret V, Riban V, Wasterlain C, Nehlig A. Role of nitric oxide in cerebral blood flow changes during kainate seizures in mice: genetic and pharmacological approaches. Neurobiology of Disease. 18: 270-81. PMID 15686955 DOI: 10.1016/J.Nbd.2004.09.014 |
0.345 |
|
| 2004 |
Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. The European Journal of Neuroscience. 19: 3235-44. PMID 15217380 DOI: 10.1111/J.0953-816X.2004.03449.X |
0.427 |
|
| 2002 |
Wasterlain CG, Niquet J, Thompson KW, Baldwin R, Liu H, Sankar R, Mazarati AM, Naylor D, Katsumori H, Suchomelova L, Shirasaka Y. Seizure-induced neuronal death in the immature brain. Progress in Brain Research. 135: 335-53. PMID 12143353 DOI: 10.1016/S0079-6123(02)35031-3 |
0.337 |
|
| 2002 |
Sankar R, Shin D, Liu H, Wasterlain C, Mazarati A. Epileptogenesis during development: injury, circuit recruitment, and plasticity. Epilepsia. 43: 47-53. PMID 12121295 DOI: 10.1046/J.1528-1157.43.S.5.11.X |
0.413 |
|
| 2002 |
Wasterlain CG, Mazarati AM, Naylor D, Niquet J, Liu H, Suchomelova L, Baldwin R, Katsumori H, Shirasaka Y, Shin D, Sankar R. Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus. Epilepsia. 43: 20-9. PMID 12121290 DOI: 10.1046/J.1528-1157.43.S.5.1.X |
0.309 |
|
| 2002 |
Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf BR, Shi TS, Hökfelt T, Wasterlain C, Bartfai T, Langel U. Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proceedings of the National Academy of Sciences of the United States of America. 99: 7136-41. PMID 12011470 DOI: 10.1073/pnas.102163499 |
0.327 |
|
| 2000 |
Sankar R, Shin D, Mazarati AM, Liu H, Katsumori H, Lezama R, Wasterlain CG. Epileptogenesis after status epilepticus reflects age- and model-dependent plasticity. Annals of Neurology. 48: 580-9. PMID 11026441 DOI: 10.1002/1531-8249(200010)48:4<580::AID-ANA4>3.0.CO;2-B |
0.313 |
|
| 2000 |
Wasterlain CG, Liu H, Mazarati AM, Baldwin RA, Shirasaka Y, Katsumori H, Thompson KW, Sankar R, Pereira de Vasconselos A, Nehlig A. Self-sustaining status epilepticus: a condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptide neuromodulators. Epilepsia. 41: S134-43. PMID 10999535 DOI: 10.1111/J.1528-1157.2000.Tb01572.X |
0.314 |
|
| 2000 |
Sankar R, Shin D, Liu H, Katsumori H, Wasterlain CG. Granule cell neurogenesis after status epilepticus in the immature rat brain. Epilepsia. 41: S53-6. PMID 10999520 DOI: 10.1111/J.1528-1157.2000.Tb01557.X |
0.334 |
|
| 2000 |
Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA, Wynick D, Wasterlain CG. Modulation of hippocampal excitability and seizures by galanin. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 6276-81. PMID 10934278 DOI: 10.1523/Jneurosci.20-16-06276.2000 |
0.307 |
|
| 1999 |
Liu H, Cao Y, Basbaum AI, Mazarati AM, Sankar R, Wasterlain CG. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. Proceedings of the National Academy of Sciences of the United States of America. 96: 12096-101. PMID 10518582 DOI: 10.1073/pnas.96.21.12096 |
0.311 |
|
| 1999 |
Theodore W, Wasterlain CG. Do early seizures beget epilepsy? Neurology. 53: 898-9. PMID 10496241 DOI: 10.1212/Wnl.53.5.898 |
0.305 |
|
| 1999 |
Pereira de Vasconcelos A, Mazarati AM, Wasterlain CG, Nehlig A. Self-sustaining status epilepticus after a brief electrical stimulation of the perforant path: a 2-deoxyglucose study. Brain Research. 838: 110-8. PMID 10446323 DOI: 10.1016/S0006-8993(99)01729-1 |
0.303 |
|
| 1999 |
Mazarati A, Liu H, Wasterlain C. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus. Neuroscience. 89: 167-73. PMID 10051226 DOI: 10.1016/S0306-4522(98)00320-0 |
0.345 |
|
| 1998 |
Thompson K, Holm AM, Schousboe A, Popper P, Micevych P, Wasterlain C. Hippocampal stimulation produces neuronal death in the immature brain. Neuroscience. 82: 337-48. PMID 9466446 DOI: 10.1016/S0306-4522(97)00195-4 |
0.359 |
|
| 1997 |
Thompson K, Wasterlain C. Lithium-pilocarpine status epilepticus in the immature rabbit. Brain Research. Developmental Brain Research. 100: 1-4. PMID 9174239 DOI: 10.1016/S0165-3806(96)00209-X |
0.418 |
|
| 1997 |
Thompson K, Wasterlain C. Partial protection of hippocampal neurons by MK-801 during perforant path stimulation in the immature brain. Brain Research. 751: 96-101. PMID 9098572 DOI: 10.1016/S0006-8993(96)01391-1 |
0.325 |
|
| 1997 |
Kornblum HI, Sankar R, Shin DH, Wasterlain CG, Gall CM. Induction of brain derived neurotrophic factor mRNA by seizures in neonatal and juvenile rat brain. Brain Research. Molecular Brain Research. 44: 219-28. PMID 9073163 DOI: 10.1016/S0169-328X(96)00224-0 |
0.308 |
|
| 1996 |
Wasterlain CG, Shirasaka Y, Mazarati AM, Spigelman I. Chronic epilepsy with damage restricted to the hippocampus: possible mechanisms. Epilepsy Research. 26: 255-65. PMID 8985705 DOI: 10.1016/S0920-1211(96)00058-7 |
0.302 |
|
| 1988 |
Bronstein J, Farber D, Wasterlain C. Decreased calmodulin kinase activity after status epilepticus. Neurochemical Research. 13: 83-6. PMID 2835695 DOI: 10.1007/Bf00971859 |
0.355 |
|
| 1986 |
Wasterlain CG, Farber DB. Cyclic nucleotide response of the hippocampal formation to septal stimulation in naive and kindled rats. Journal of Neurochemistry. 47: 185-90. PMID 3711899 DOI: 10.1111/J.1471-4159.1986.Tb02848.X |
0.325 |
|
| 1986 |
Wasterlain CG, Farber DB, Fairchild MD. Synaptic mechanisms in the kindled epileptic focus: a speculative synthesis. Advances in Neurology. 44: 411-33. PMID 2871722 |
0.336 |
|
| 1985 |
Wasterlain CG, Farber DB, Fairchild D. Cholinergic kindling: what has it taught us about epilepsy? Journal of Neural Transmission. 63: 119-32. PMID 3900291 DOI: 10.1007/BF01252612 |
0.316 |
|
| 1980 |
Suga S, Wasterlain CG. Effects of neonatal seizures or anoxia on cerebellar mitotic activity in the rat. Experimental Neurology. 67: 573-80. PMID 7353616 DOI: 10.1016/0014-4886(80)90127-2 |
0.307 |
|
| 1973 |
Wasterlain CG, Plum F. Vulnerability of developing rat brain to electroconvulsive seizures. Archives of Neurology. 29: 38-45. PMID 4711803 DOI: 10.1001/archneur.1973.00490250056006 |
0.302 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2002 |
Mazarati A, Bragin A, Baldwin R, Shin D, Wilson C, Sankar R, Naylor D, Engel J, Wasterlain CG. Epileptogenesis after self-sustaining status epilepticus. Epilepsia. 43: 74-80. PMID 12121299 DOI: 10.1046/J.1528-1157.43.S.5.25.X |
0.3 |
|
| 1998 |
Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, Wasterlain CG. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 10070-7. PMID 9822761 |
0.299 |
|
| 1998 |
Mazarati AM, Wasterlain CG, Sankar R, Shin D. Self-sustaining status epilepticus after brief electrical stimulation of the perforant path. Brain Research. 801: 251-3. PMID 9729413 DOI: 10.1016/S0006-8993(98)00606-4 |
0.29 |
|
| 2006 |
Wasterlain CG. Invulnerability of the immature brain to seizures: do dogmas have nine lives? Epilepsy Currents / American Epilepsy Society. 6: 59-61. PMID 16604205 DOI: 10.1111/j.1535-7511.2006.00099.x |
0.29 |
|
| 1975 |
Wasterlain CG. Developmental brain damage after chemically induced epileptic seizures. European Neurology. 13: 495-8. PMID 1193096 |
0.289 |
|
| 1980 |
Dwyer BE, Wasterlain CG. Seizures adversely affect myelination in immature rat brain Neurology. 30: E 8. |
0.288 |
|
| 1993 |
Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia. 34: S37-53. PMID 8385002 DOI: 10.1111/J.1528-1157.1993.Tb05905.X |
0.286 |
|
| 1979 |
Wasterlain CG. Does anoxemia play a role in the effects of neonatal seizures on brain growth? An experimental study in the rat. European Neurology. 18: 222-9. PMID 488139 DOI: 10.1159/000115080 |
0.286 |
|
| 1980 |
Wasterlain CG, Csiszar E. Cyclic nucleotide metabolism in mouse brain during seizures induced by bicuculline or dibutyryl cyclic guanosine monophosphate. Experimental Neurology. 70: 260-8. PMID 6253313 |
0.286 |
|
| 2017 |
Torolira D, Suchomelova L, Wasterlain CG, Niquet J. Phenobarbital and Midazolam Increase Neonatal Seizure-Associated Neuronal Injury. Annals of Neurology. PMID 28556259 DOI: 10.1002/ana.24967 |
0.283 |
|
| 2019 |
Lumley LA, Rossetti F, de Araujo Furtado M, Marrero-Rosado B, Schultz CR, Schultz MK, Niquet J, Wasterlain CG. Dataset of EEG power integral, spontaneous recurrent seizure and behavioral responses following combination drug therapy in soman-exposed rats. Data in Brief. 27: 104629. PMID 31687442 DOI: 10.1016/J.Dib.2019.104629 |
0.283 |
|
| 1999 |
Wasterlain CG, Mazarati AM, Shirasaka Y, Thompson KW, Penix L, Liu H, Katsumori H. Seizure-induced hippocampal damage and chronic epilepsy: a hebbian theory of epileptogenesis. Advances in Neurology. 79: 829-43. PMID 10514867 |
0.283 |
|
| 1979 |
Jonec V, Wasterlain CG. Effect of inhibitors of protein synthesis on the development of kindled seizures in rats Experimental Neurology. 66: 524-532. PMID 488236 DOI: 10.1016/0014-4886(79)90199-7 |
0.283 |
|
| 2004 |
Niquet J, Wasterlain CG. Bim, Bad, and Bax: a deadly combination in epileptic seizures. The Journal of Clinical Investigation. 113: 960-2. PMID 15057301 DOI: 10.1172/JCI21478 |
0.281 |
|
| 1980 |
Jørgensen OS, Dwyer B, Wasterlain CG. Synaptic proteins after electroconvulsive seizures in immature rats. Journal of Neurochemistry. 35: 1235-7. PMID 6109006 |
0.281 |
|
| 1997 |
Wasterlain CG. Recurrent seizures in the developing brain are harmful. Epilepsia. 38: 728-34. PMID 9186257 DOI: 10.1111/j.1528-1157.1997.tb01244.x |
0.281 |
|
| 1976 |
Wasterlain CG. Developmental effects of seizures: role of malnutrition. Pediatrics. 57: 197-200. PMID 1250655 |
0.28 |
|
| 2011 |
Wasterlain CG, Baldwin R, Naylor DE, Thompson KW, Suchomelova L, Niquet J. Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia. 52: 70-1. PMID 21967369 DOI: 10.1111/j.1528-1167.2011.03243.x |
0.276 |
|
| 1977 |
Wasterlain CG. Effects of neonatal seizures on ontogeny of reflexes and behavior. An experimental study in the rat. European Neurology. 15: 9-19. PMID 856589 DOI: 10.1159/000114783 |
0.276 |
|
| 2000 |
Liu H, Sankar R, Shin DH, Mazarati AM, Wasterlain CG. Patterns of status epilepticus-induced substance P expression during development. Neuroscience. 101: 297-304. PMID 11074153 DOI: 10.1016/S0306-4522(00)00383-3 |
0.276 |
|
| 1982 |
Wasterlain CG, Farber DB. A lasting change in protein phosphorylation associated with septal kindling. Brain Research. 247: 191-4. PMID 7127118 DOI: 10.1016/0006-8993(82)91050-2 |
0.274 |
|
| 1980 |
Wasterlain CG, Jonec V. Muscarinic kindling: transsynaptic generation of a chronic seizure focus. Life Sciences. 26: 387-91. PMID 7366329 DOI: 10.1016/0024-3205(80)90155-1 |
0.274 |
|
| 2020 |
Lumley L, Niquet J, Marrero-Rosado B, Schultz M, Rossetti F, de Araujo Furtado M, Wasterlain C. Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors. Neuropharmacology. 108444. PMID 33359073 DOI: 10.1016/j.neuropharm.2020.108444 |
0.274 |
|
| 1982 |
Dwyer BE, Wasterlain CG. Electroconvulsive seizures in the immature rat adversely affect myelin accumulation. Experimental Neurology. 78: 616-28. PMID 7173373 DOI: 10.1016/0014-4886(82)90079-6 |
0.274 |
|
| 1973 |
Wasterlain CG, Plum F. Retardation of behavioral landmarks after neonatal seizures in rats. Transactions of the American Neurological Association. 98: 320-1. PMID 4798992 |
0.273 |
|
| 1997 |
Mazarati AM, Wasterlain CG. Selective facilitation of kindled seizures from the amygdala after hippocampal lesions induced by perforant path stimulation. Neuroscience Letters. 224: 165-8. PMID 9131662 DOI: 10.1016/S0304-3940(97)00164-X |
0.272 |
|
| 2006 |
Suchomelova L, Baldwin RA, Kubova H, Thompson KW, Sankar R, Wasterlain CG. Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Pediatric Research. 59: 237-43. PMID 16439585 DOI: 10.1203/01.Pdr.0000196333.16608.30 |
0.272 |
|
| 1979 |
Fando JL, Conn M, Wasterlain CG. Brain protein synthesis during neonatal seizures: an experimental study. Experimental Neurology. 63: 220-8. PMID 437000 DOI: 10.1016/0014-4886(79)90119-5 |
0.271 |
|
| 2017 |
Niquet J, Suchomelova L, Thompson K, Klitgaard H, Matagne A, Wasterlain C. Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus. Epilepsia. PMID 28597912 DOI: 10.1111/epi.13787 |
0.27 |
|
| 1984 |
Dwyer BE, Wasterlain CG. Selective focal inhibition of brain protein synthesis during generalized bicuculline seizures in newborn marmoset monkeys. Brain Research. 308: 109-21. PMID 6478197 DOI: 10.1016/0006-8993(84)90922-3 |
0.267 |
|
| 2010 |
Pedersen ME, Baldwin RA, Niquet J, Stafford GI, van Staden J, Wasterlain CG, Jäger AK. Anticonvulsant effects of Searsia dentata (Anacardiaceae) leaf extract in rats. Phytotherapy Research : Ptr. 24: 924-7. PMID 19953526 DOI: 10.1002/ptr.3016 |
0.265 |
|
| 1983 |
Wasterlain CG, Dwyer BE. Brain metabolism during prolonged seizures in neonates. Advances in Neurology. 34: 241-60. PMID 6402891 |
0.264 |
|
| 1992 |
Fujikawa DG, Söderfeldt B, Wasterlain CG. Neuropathological changes during generalized seizures in newborn monkeys. Epilepsy Research. 12: 243-51. PMID 1396549 DOI: 10.1016/0920-1211(92)90078-8 |
0.264 |
|
| 2009 |
Wasterlain CG, Liu H, Naylor DE, Thompson KW, Suchomelova L, Niquet J, Mazarati AM, Baldwin RA. Molecular basis of self-sustaining seizures and pharmacoresistance during status epilepticus: The receptor trafficking hypothesis revisited. Epilepsia. 50: 16-8. PMID 19941513 DOI: 10.1111/j.1528-1167.2009.02375.x |
0.263 |
|
| 1980 |
Wasterlain CG, Jonec V. Induction of a chronic seizure focus by repeated stimulation of excitatory synapses Neurology. 30: E 3. |
0.262 |
|
| 1978 |
Wasterlain CG. Neonatal seizures and brain growth. Neuropã¤Diatrie. 9: 213-28. PMID 581397 DOI: 10.1055/s-0028-1091482 |
0.261 |
|
| 1980 |
Wasterlain CG, Masuoka D, Jonec V. Metabolic suppression of the reticular formation during absence-like seizures induced by chemical kindling Neurology. 30: E 5. |
0.261 |
|
| 1978 |
Wasterlain CG, Csiszar E. Regional changes in brain cyclic nucleotide concentrations during bicuculline seizures Neurology. 28: 381. |
0.26 |
|
| 2019 |
Niquet J, Lumley L, Baldwin R, Rossetti F, Schultz M, de Araujo Furtado M, Suchomelova L, Naylor D, Franco-Estrada I, Wasterlain CG. Early polytherapy for benzodiazepine-refractory status epilepticus. Epilepsy & Behavior : E&B. 106367. PMID 31636007 DOI: 10.1016/j.yebeh.2019.06.011 |
0.259 |
|
| 2007 |
Rocha LL, Lopez-Meraz ML, Niquet J, Wasterlain CG. Do single seizures cause neuronal death in the human hippocampus? Epilepsy Currents / American Epilepsy Society. 7: 77-81. PMID 17520081 DOI: 10.1111/j.1535-7511.2007.00178.x |
0.258 |
|
| 1998 |
Spigelman I, Yan XX, Obenaus A, Lee EY, Wasterlain CG, Ribak CE. Dentate granule cells form novel basal dendrites in a rat model of temporal lobe epilepsy. Neuroscience. 86: 109-20. PMID 9692747 DOI: 10.1016/S0306-4522(98)00028-1 |
0.258 |
|
| 1988 |
Fujikawa DG, Vannucci RC, Dwyer BE, Wasterlain CG. Generalized seizures deplete brain energy reserves in normoxemic newborn monkeys. Brain Research. 454: 51-9. PMID 3136858 DOI: 10.1016/0006-8993(88)90802-5 |
0.255 |
|
| 1977 |
Wasterlain CG. Effects of epileptic seizures on brain ribosomes: mechanism and relationship to cerebral energy metabolism. Journal of Neurochemistry. 29: 707-16. PMID 591946 |
0.255 |
|
| 1988 |
Bronstein J, Nishimura R, Lasher R, Cole R, de Vellis J, Farber D, Wasterlain C. Calmodulin kinase II in pure cultured astrocytes. Journal of Neurochemistry. 50: 45-9. PMID 2826689 DOI: 10.1111/J.1471-4159.1988.Tb13227.X |
0.249 |
|
| 1997 |
Sankar R, Shin DH, Wasterlain CG. GABA metabolism during status epilepticus in the developing rat brain. Brain Research. Developmental Brain Research. 98: 60-4. PMID 9027404 DOI: 10.1016/S0165-3806(96)00165-4 |
0.246 |
|
| 2012 |
Wasterlain C, Baldwin R, Niquet J, Suchomelova L. Treatment of Status Epilepticus: Mono- or Polytherapy? (P06.094) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.094 |
0.246 |
|
| 1986 |
Baxter CF, Wasterlain CG, Hallden KL, Pruess SF. Effect of altered blood plasma osmolalities on regional brain amino acid concentrations and focal seizure susceptibility in the rat. Journal of Neurochemistry. 47: 617-24. PMID 3090205 |
0.245 |
|
| 1980 |
Wasterlain CG, Fando JM, Subhas BS. Epilepsy and brain development. Progress in Clinical and Biological Research. 39: 101-22. PMID 6995991 |
0.243 |
|
| 2003 |
Sankar R, Shin D, Wasterlain CG. Development of temporal lobe epilepsy in 21-day-old rats. Epilepsia. 44: 872; author reply 87. PMID 12790906 DOI: 10.1046/J.1528-1157.2003.04803_1.X |
0.243 |
|
| 2019 |
Niquet J, Lumley L, Baldwin R, Rossetti F, Suchomelova L, Naylor D, Estrada IBF, Wasterlain CG. Rational polytherapy in the treatment of cholinergic seizures. Neurobiology of Disease. 104537. PMID 31454548 DOI: 10.1016/J.Nbd.2019.104537 |
0.243 |
|
| 1994 |
Wasterlain CG, Shirasaka Y. Seizures, brain damage and brain development. Brain & Development. 16: 279-95. PMID 7818023 DOI: 10.1016/0387-7604(94)90025-6 |
0.242 |
|
| 2010 |
Wasterlain CG, Thompson KW, Suchomelova L, Niquet J. Brain energy metabolism during experimental neonatal seizures. Neurochemical Research. 35: 2193-8. PMID 21136154 DOI: 10.1007/s11064-010-0339-4 |
0.24 |
|
| 2015 |
Torolira D, Suchomelova L, Wasterlain CG, Niquet J. Widespread neuronal injury in a model of cholinergic status epilepticus in postnatal day 7 rat pups. Epilepsy Research. 120: 47-54. PMID 26709882 DOI: 10.1016/j.eplepsyres.2015.11.005 |
0.239 |
|
| 2002 |
Wasterlain C, Cavalheiro EA. Ictogenesis and epileptogenesis: Papers presented at the Sixth Workshop on the Neurobiology of Epilepsy (WONOEP VI). Preface Epilepsia. 43: 1-2. |
0.238 |
|
| 1999 |
Liu H, Mazarati AM, Katsumori H, Sankar R, Wasterlain CG. Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proceedings of the National Academy of Sciences of the United States of America. 96: 5286-91. PMID 10220458 DOI: 10.1073/pnas.96.9.5286 |
0.237 |
|
| 1986 |
Dwyer BE, Fujikawa DG, Wasterlain CG. Metabolic anatomy of generalized bicuculline seizures in the newborn marmoset monkey. Experimental Neurology. 94: 213-27. PMID 3093261 DOI: 10.1016/0014-4886(86)90284-0 |
0.235 |
|
| 1991 |
Baxter CF, Oh CC, Wasterlain CG, Ozaki LK, Baldwin RA. Alterations of GABA metabolism and seizure susceptibility in the substantia nigra of the kindled rat acclimating to changes in osmotic state. Neurochemical Research. 16: 269-78. PMID 1780028 DOI: 10.1007/BF00966090 |
0.233 |
|
| 1998 |
Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Research. 814: 179-85. PMID 9838100 DOI: 10.1016/S0006-8993(98)01080-4 |
0.232 |
|
| 2017 |
Niquet J, Baldwin R, Norman K, Suchomelova L, Lumley L, Wasterlain CG. Simultaneous triple therapy for the treatment of status epilepticus. Neurobiology of Disease. PMID 28461248 DOI: 10.1016/j.nbd.2017.04.019 |
0.231 |
|
| 2015 |
Niquet J, Gezalian M, Baldwin R, Wasterlain CG. Neuroprotective effects of deep hypothermia in refractory status epilepticus. Annals of Clinical and Translational Neurology. 2: 1105-15. PMID 26734661 DOI: 10.1002/acn3.262 |
0.23 |
|
| 1974 |
Wasterlain CG. Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations. Neurology. 24: 175-80. PMID 4855687 |
0.228 |
|
| 2009 |
Chen JW, Ruff RL, Eavey R, Wasterlain CG. Posttraumatic epilepsy and treatment. Journal of Rehabilitation Research and Development. 46: 685-96. PMID 20104398 DOI: 10.1682/JRRD.2008.09.0130 |
0.227 |
|
| 1992 |
Bronstein JM, Micevych P, Popper P, Huez G, Farber DB, Wasterlain CG. Long-lasting decreases of type II calmodulin kinase expression in kindled rat brains. Brain Research. 584: 257-60. PMID 1325246 DOI: 10.1016/0006-8993(92)90903-M |
0.225 |
|
| 2002 |
Mazarati A, Wasterlain CG. Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus. Neuroscience Letters. 331: 123-7. PMID 12361856 DOI: 10.1016/S0304-3940(02)00847-9 |
0.218 |
|
| 1976 |
Wasterlain CG. Effects of neonatal status epilepticus on rat brain development. Neurology. 26: 975-86. PMID 986588 |
0.216 |
|
| 2010 |
Lopez-Meraz ML, Wasterlain CG, Rocha LL, Allen S, Niquet J. Vulnerability of postnatal hippocampal neurons to seizures varies regionally with their maturational stage. Neurobiology of Disease. 37: 394-402. PMID 19879360 DOI: 10.1016/j.nbd.2009.10.019 |
0.214 |
|
| 1983 |
Morin AM, Watson AL, Wasterlain CG. Kindling of seizures with norharman, a beta-carboline ligand of benzodiazepine receptors. European Journal of Pharmacology. 88: 131-4. PMID 6303806 DOI: 10.1016/0014-2999(83)90402-8 |
0.213 |
|
| 1986 |
Fujikawa DG, Dwyer BE, Wasterlain CG. Preferential blood flow to brainstem during generalized seizures in the newborn marmoset monkey. Brain Research. 397: 61-72. PMID 3801866 DOI: 10.1016/0006-8993(86)91369-7 |
0.213 |
|
| 1999 |
Sankar R, Shin D, Mazarati AM, Liu H, Wasterlain CG. Ontogeny of self-sustaining status epilepticus. Developmental Neuroscience. 21: 345-51. PMID 10575258 DOI: 10.1159/000017384 |
0.212 |
|
| 1995 |
Pereira de Vasconcelos A, Baldwin RA, Wasterlain CG. Nitric oxide mediates the increase in local cerebral blood flow during focal seizures. Proceedings of the National Academy of Sciences of the United States of America. 92: 3175-9. PMID 7536926 |
0.211 |
|
| 1984 |
Wasterlain CG, Farber DB. Kindling alters the calcium/calmodulin-dependent phosphorylation of synaptic plasma membrane proteins in rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America. 81: 1253-7. PMID 6322192 DOI: 10.1073/Pnas.81.4.1253 |
0.21 |
|
| 1974 |
Wasterlain CG. Mortality and morbidity from serial seizures. An experimental study. Epilepsia. 15: 155-76. PMID 4525503 |
0.21 |
|
| 1990 |
Wu K, Wasterlain C, Sachs L, Siekevitz P. Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America. 87: 5298-302. PMID 2164674 DOI: 10.1073/pnas.87.14.5298 |
0.207 |
|
| 1981 |
Painter MJ, Pippenger C, Wasterlain C, Barmada M, Pitlick W, Carter G, Abern S. Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution. Neurology. 31: 1107-12. PMID 7196530 |
0.205 |
|
| 2002 |
Tan Z, Sankar R, Shin D, Sun N, Liu H, Wasterlain CG, Schreiber SS. Differential induction of p53 in immature and adult rat brain following lithium-pilocarpine status epilepticus. Brain Research. 928: 187-93. PMID 11844486 DOI: 10.1016/S0006-8993(01)03359-5 |
0.205 |
|
| 1993 |
Wasterlain CG, Adams LM, Schwartz PH, Hattori H, Sofia RD, Wichmann JK. Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia. Neurology. 43: 2303-10. PMID 8232947 DOI: 10.1212/WNL.43.11.2303 |
0.205 |
|
| 2007 |
Niquet J, Auvin S, Archie M, Seo DW, Allen S, Sankar R, Wasterlain CG. Status epilepticus triggers caspase-3 activation and necrosis in the immature rat brain. Epilepsia. 48: 1203-6. PMID 17441993 DOI: 10.1111/J.1528-1167.2007.01102.X |
0.203 |
|
| 2002 |
Mazarati AM, Sofia RD, Wasterlain CG. Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus. Seizure. 11: 423-30. PMID 12237067 DOI: 10.1053/seiz.2002.0677 |
0.201 |
|
| 2005 |
Walker M, Cross H, Smith S, Young C, Aicardi J, Appleton R, Aylett S, Besag F, Cock H, DeLorenzo R, Drislane F, Duncan J, Ferrie C, Fujikawa D, Gray W, ... ... Wasterlain C, et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disorders : International Epilepsy Journal With Videotape. 7: 253-96. PMID 16162436 |
0.198 |
|
| 1986 |
Dwyer BE, Wasterlain CG, Fujikawa DG, Yamada L. Brain protein metabolism in epilepsy. Advances in Neurology. 44: 903-18. PMID 2422896 |
0.197 |
|
| 1983 |
Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. Status epilepticus: summary. Advances in Neurology. 34: 537-41. PMID 6829359 |
0.195 |
|
| 2015 |
Suchomelova L, Lopez-Meraz ML, Niquet J, Kubova H, Wasterlain CG. Hyperthermia aggravates status epilepticus-induced epileptogenesis and neuronal loss in immature rats. Neuroscience. 305: 209-24. PMID 26259902 DOI: 10.1016/j.neuroscience.2015.08.006 |
0.194 |
|
| 2004 |
Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Research. 58: 167-74. PMID 15120747 DOI: 10.1016/j.eplepsyres.2004.02.002 |
0.194 |
|
| 1990 |
Bronstein JM, Farber DB, Micevych PE, Lasher R, Wasterlain CG. Kindling induced changes in calmodulin kinase II immunoreactivity. Brain Research. 524: 49-53. PMID 2169328 DOI: 10.1016/0006-8993(90)90490-3 |
0.192 |
|
| 2002 |
Tan Z, Sankar R, Tu W, Shin D, Liu H, Wasterlain CG, Schreiber SS. Immunohistochemical study of p53-associated proteins in rat brain following lithium-pilocarpine status epilepticus. Brain Research. 929: 129-38. PMID 11852039 DOI: 10.1016/S0006-8993(01)03360-1 |
0.191 |
|
| 1992 |
Wallis RA, Panizzon KL, Fairchild MD, Wasterlain CG. Protective effects of felbamate against hypoxia in the rat hippocampal slice. Stroke; a Journal of Cerebral Circulation. 23: 547-51. PMID 1561687 |
0.19 |
|
| 1994 |
Shirasaka Y, Wasterlain CG. Chronic epileptogenicity following focal status epilepticus. Brain Research. 655: 33-44. PMID 7812788 DOI: 10.1016/0006-8993(94)91594-6 |
0.185 |
|
| 1994 |
Penix LP, Wasterlain CG. Selective protection of neuropeptide containing dentate hilar interneurons by non-NMDA receptor blockade in an animal model of status epilepticus. Brain Research. 644: 19-24. PMID 8032945 DOI: 10.1016/0006-8993(94)90341-7 |
0.185 |
|
| 1992 |
Wasterlain CG, Adams LM, Hattori H, Schwartz PH. Felbamate reduces hypoxic-ischemic brain damage in vivo. European Journal of Pharmacology. 212: 275-8. PMID 1601070 DOI: 10.1016/0014-2999(92)90343-3 |
0.184 |
|
| 2021 |
Lumley LA, Marrero-Rosado B, Rossetti F, Schultz CR, Stone MF, Niquet J, Wasterlain CG. Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats. Epilepsia Open. PMID 34657398 DOI: 10.1002/epi4.12552 |
0.183 |
|
| 1992 |
Schwartz PH, Massarweh WF, Vinters HV, Wasterlain CG. A rat model of severe neonatal hypoxic-ischemic brain injury. Stroke; a Journal of Cerebral Circulation. 23: 539-46. PMID 1561686 DOI: 10.1161/01.STR.23.4.539 |
0.182 |
|
| 1976 |
Wasterlain CG, Duffy TE. Status epilepticus in immature rats. Protective effects of glucose on survival and brain development. Archives of Neurology. 33: 821-7. PMID 999545 |
0.182 |
|
| 1983 |
Wasterlain CG, Jonec V. Chemical kindling by muscarinic amygdaloid stimulation in the rat. Brain Research. 271: 311-23. PMID 6616179 DOI: 10.1016/0006-8993(83)90293-7 |
0.179 |
|
| 1997 |
Mazarati AM, Wasterlain CG. Blockers of NMDA receptor restore paired-pulse inhibition in the rat dentate gyrus lesioned by perforant path stimulation. Neuroscience Letters. 234: 135-8. PMID 9364516 DOI: 10.1016/S0304-3940(97)00693-9 |
0.178 |
|
| 1996 |
Wasterlain CG, Adams LM, Wichmann JK, Sofia RD. Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia. Stroke; a Journal of Cerebral Circulation. 27: 1236-40. PMID 8685935 |
0.177 |
|
| 1973 |
Menkes J, Wasterlain C. Sections on Child Neurology and Neurochemistry (Joint Session) Neurology. 23: 427-427. DOI: 10.1212/Wnl.23.4.427 |
0.176 |
|
| 1980 |
Fando JL, Salinas M, Wasterlain CG. Age-dependent changes in brain protein synthesis in the rat. Neurochemical Research. 5: 373-83. PMID 6770276 DOI: 10.1007/BF00964226 |
0.175 |
|
| 1985 |
Dwyer BE, Wasterlain CG. Neonatal seizures in monkeys and rabbits: brain glucose depletion in the face of normoglycemia, prevention by glucose loads. Pediatric Research. 19: 992-5. PMID 3932954 DOI: 10.1203/00006450-198510000-00005 |
0.175 |
|
| 1982 |
Engel J, Troupin AS, Crandall PH, Sterman MB, Wasterlain CG. Recent developments in the diagnosis and therapy of epilepsy. Annals of Internal Medicine. 97: 584-98. PMID 6812475 |
0.175 |
|
| 1972 |
Wasterlain CG. Breakdown of brain polysomes in status epilepticus. Brain Research. 39: 278-84. PMID 5025652 |
0.169 |
|
| 2017 |
Niquet J, Baldwin R, Suchomelova L, Lumley L, Eavey R, Wasterlain CG. Treatment of experimental status epilepticus with synergistic drug combinations. Epilepsia. PMID 28225161 DOI: 10.1111/epi.13695 |
0.169 |
|
| 2016 |
Niquet J, Baldwin R, Norman K, Suchomelova L, Lumley L, Wasterlain CG. Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits. Epilepsia. PMID 27500978 DOI: 10.1111/epi.13480 |
0.168 |
|
| 1997 |
Sankar R, Shin DH, Wasterlain CG. Serum neuron-specific enolase is a marker for neuronal damage following status epilepticus in the rat. Epilepsy Research. 28: 129-36. PMID 9267777 DOI: 10.1016/S0920-1211(97)00040-5 |
0.168 |
|
| 2019 |
Baumhefner R, Wasterlain C, Mishra S, Murthy K. In Memory of Wallace William Tourtellotte, MD, PhD (1924-2019). Annals of Neurology. PMID 31875425 DOI: 10.1002/ana.25659 |
0.166 |
|
| 2007 |
Chen JW, Naylor DE, Wasterlain CG. Advances in the pathophysiology of status epilepticus. Acta Neurologica Scandinavica. Supplementum. 186: 7-15. PMID 17784531 |
0.164 |
|
| 2007 |
Chen JW, Naylor DE, Wasterlain CG. Advances in the pathophysiology of status epilepticus. Acta Neurologica Scandinavica. 115: 7-15. PMID 17362270 DOI: 10.1111/j.1600-0404.2007.00803.x |
0.164 |
|
| 2015 |
Niquet J, Baldwin R, Gezalian M, Wasterlain CG. Deep hypothermia for the treatment of refractory status epilepticus. Epilepsy & Behavior : E&B. 49: 313-7. PMID 26198217 DOI: 10.1016/j.yebeh.2015.06.028 |
0.163 |
|
| 2015 |
Niquet J, Baldwin R, Gezalian M, Wasterlain CG. Deep hypothermia for the treatment of refractory status epilepticus Epilepsy and Behavior. 49: 313-317. DOI: 10.1016/j.yebeh.2015.06.028 |
0.163 |
|
| 1993 |
Thompson KW, Wasterlain CG. Dextromethorphan and its combination with phenytoin facilitate kindling. Neurology. 43: 992-4. PMID 8492958 |
0.162 |
|
| 1980 |
Morin AM, Wasterlain CG. Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding. Neurochemical Research. 5: 301-8. PMID 7374884 DOI: 10.1007/BF00964618 |
0.16 |
|
| 2016 |
Niquet J, Baldwin R, Suchomelova L, Lumley L, Naylor D, Eavey R, Wasterlain CG. Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment. Annals of the New York Academy of Sciences. PMID 27392038 DOI: 10.1111/nyas.13147 |
0.16 |
|
| 2014 |
Benz AP, Niquet J, Wasterlain CG, Rami A. Status epilepticus in the immature rodent brain alters the dynamics of autophagy. Current Neurovascular Research. 11: 125-35. PMID 24597603 DOI: 10.2174/1567202611666140305215009 |
0.16 |
|
| 1991 |
Hattori H, Wasterlain CG. Hypothermia does not explain MK-801 neuroprotection in a rat model of neonatal hypoxic-ischemic encephalopathy. Neurology. 41: 330. PMID 1992389 |
0.159 |
|
| 1992 |
Wasterlain CG, Bronstein JM, Morin AM, Dwyer BE, Sankar R. Translocation and autophosphorylation of brain calmodulin kinase II in status epilepticus. Epilepsy Research. Supplement. 9: 231-8. PMID 1337440 |
0.159 |
|
| 1981 |
Jonec V, Wasterlain CG. Anticonvulsants block chemical kindling Neurology. 31: 157. |
0.159 |
|
| 1986 |
Goldenring JR, Wasterlain CG, Oestreicher AB, de Graan PN, Farber DB, Glaser G, DeLorenzo RJ. Kindling induces a long-lasting change in the activity of a hippocampal membrane calmodulin-dependent protein kinase system. Brain Research. 377: 47-53. PMID 3730855 DOI: 10.1016/0006-8993(86)91189-3 |
0.158 |
|
| 1993 |
Goodman JH, Wasterlain CG, Massarweh WF, Dean E, Sollas AL, Sloviter RS. Calbindin-D28k immunoreactivity and selective vulnerability to ischemia in the dentate gyrus of the developing rat. Brain Research. 606: 309-14. PMID 8490723 DOI: 10.1016/0006-8993(93)90999-4 |
0.155 |
|
| 2019 |
Tourtellotte WG, Mishra S, Murthy K, Wasterlain C, Baumhefner R. Wallace William Tourtellotte, MD, PhD September 13, 1924-July 29, 2019. Journal of Neuropathology and Experimental Neurology. PMID 31697331 DOI: 10.1093/jnen/nlz104 |
0.153 |
|
| 1998 |
Spigelman I, Obenaus A, Mazarati A, Wasterlain CG. Intravenously administered cell-permeant calcium buffer decreases evoked synaptic potentials in rat dentate gyrus in vivo. Brain Research. 810: 269-73. PMID 9813363 DOI: 10.1016/S0006-8993(98)00912-3 |
0.151 |
|
| 1969 |
Wasterlain C, Dhaene R. [Familial sensory epilepsy]. Acta Neurologica Et Psychiatrica Belgica. 69: 734-42. PMID 4998489 |
0.151 |
|
| 1986 |
Wasterlain CG, Csiszar E, Fairchild MD. Habituation of the local cyclic GMP response during amygdaloid carbachol kindling in the rat. Brain Research. 397: 345-52. PMID 3026560 DOI: 10.1016/0006-8993(86)90637-2 |
0.149 |
|
| 1978 |
Wasterlain CG, Lockwood AH, Conn M. Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat. Neurology. 28: 233-8. PMID 564477 |
0.149 |
|
| 1998 |
Pulera MR, Adams LM, Liu H, Santos DG, Nishimura RN, Yang F, Cole GM, Wasterlain CG. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke; a Journal of Cerebral Circulation. 29: 2622-30. PMID 9836776 |
0.148 |
|
| 1983 |
Morin AM, Wasterlain CG. Role of receptors for neurotransmitters in status epilepticus. Advances in Neurology. 34: 369-74. PMID 6299075 |
0.148 |
|
| 2011 |
Wasterlain CG, Stöhr T, Matagne A. The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus. Epilepsy Research. 94: 10-7. PMID 21277168 DOI: 10.1016/j.eplepsyres.2010.12.014 |
0.147 |
|
| 1999 |
Mazarati AM, Wasterlain CG. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neuroscience Letters. 265: 187-90. PMID 10327162 DOI: 10.1016/S0304-3940(99)00238-4 |
0.147 |
|
| 1990 |
Hattori H, Wasterlain CG. Posthypoxic glucose supplement reduces hypoxic-ischemic brain damage in the neonatal rat. Annals of Neurology. 28: 122-8. PMID 2221842 DOI: 10.1002/ana.410280203 |
0.146 |
|
| 1980 |
Dwyer BE, Fando JL, Wasterlain CG. Rat brain protein synthesis declines during postdevelopmental aging. Journal of Neurochemistry. 35: 746-9. PMID 6778965 |
0.146 |
|
| 1983 |
Dwyer BE, Wasterlain CG. Regulation of brain protein synthesis during status epilepticus. Advances in Neurology. 34: 297-304. PMID 6829338 |
0.145 |
|
| 1989 |
Hattori H, Morin AM, Schwartz PH, Fujikawa DG, Wasterlain CG. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology. 39: 713-8. PMID 2651970 DOI: 10.1212/WNL.39.5.713 |
0.143 |
|
| 1989 |
Morin AM, Hattori H, Wasterlain CG, Thomson D. [3H]MK-801 binding sites in neonate rat brain. Brain Research. 487: 376-9. PMID 2567199 DOI: 10.1016/0006-8993(89)90844-5 |
0.142 |
|
| 1993 |
Bronstein JM, Farber DB, Wasterlain CG. Regulation of type-II calmodulin kinase: functional implications. Brain Research. Brain Research Reviews. 18: 135-47. PMID 8385527 DOI: 10.1016/0165-0173(93)90011-N |
0.142 |
|
| 1982 |
Wasterlain CG, Morin AM, Jonec V. Interactions between chemical and electrical kindling of the rat amygdala. Brain Research. 247: 341-6. PMID 7127133 DOI: 10.1016/0006-8993(82)91259-8 |
0.142 |
|
| 1981 |
Wasterlain CG, Jonec V. Cholinergic kindling of the amygdala requires the activation of muscarinic receptors. Experimental Neurology. 73: 595-9. PMID 7262259 DOI: 10.1016/0014-4886(81)90294-6 |
0.141 |
|
| 1993 |
McCabe RT, Wasterlain CG, Kucharczyk N, Sofia RD, Vogel JR. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. The Journal of Pharmacology and Experimental Therapeutics. 264: 1248-52. PMID 8383742 |
0.14 |
|
| 1992 |
Parsons JE, Wallis RA, Panizzon KL, Wasterlain CG. Low sodium injury in the hippocampal slice is mediated through NMDA receptors. Brain Research. 595: 141-4. PMID 1467950 DOI: 10.1016/0006-8993(92)91464-P |
0.138 |
|
| 2010 |
Lopez-Meraz ML, Niquet J, Wasterlain CG. Distinct caspase pathways mediate necrosis and apoptosis in subpopulations of hippocampal neurons after status epilepticus. Epilepsia. 51: 56-60. PMID 20618402 DOI: 10.1111/j.1528-1167.2010.02611.x |
0.136 |
|
| 2013 |
Wasterlain CG, Naylor DE, Liu H, Niquet J, Baldwin R. Trafficking of NMDA receptors during status epilepticus: therapeutic implications. Epilepsia. 54: 78-80. PMID 24001081 DOI: 10.1111/epi.12285 |
0.135 |
|
| 2013 |
Wasterlain CG, Gloss DS, Niquet J, Wasterlain AS. Epileptogenesis in the developing brain. Handbook of Clinical Neurology. 111: 427-39. PMID 23622191 DOI: 10.1016/B978-0-444-52891-9.00046-4 |
0.134 |
|
| 1978 |
Wasterlain CG, Jonec V, Holm SJ. Cholinergic kindling: a transsynaptic phenomenon requiring the activation of muscarinic receptors Neurology. 28: 346. |
0.134 |
|
| 1977 |
Wasterlain CG, Fando JL, Lieber CS. Chronic alcohol ingestion inhibits rat brain protein synthesis Neurology. 27: 385. |
0.132 |
|
| 1998 |
Sankar R, Shin DH, Liu H, Mazarati A, Pereira de Vasconcelos A, Wasterlain CG. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 8382-93. PMID 9763481 |
0.131 |
|
| 2013 |
Naylor DE, Liu H, Niquet J, Wasterlain CG. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiology of Disease. 54: 225-38. PMID 23313318 DOI: 10.1016/j.nbd.2012.12.015 |
0.129 |
|
| 2006 |
Mazarati AM, Thompson KW, Suchomelova L, Sankar R, Shirasaka Y, Nissinen J, Pitkänen A, Bertram EH, Wasterlain C. Status Epilepticus: Electrical Stimulation Models Models of Seizures and Epilepsy. 449-464. DOI: 10.1016/B978-012088554-1/50038-4 |
0.129 |
|
| 1983 |
Kameyama M, Wasterlain CG, Ackermann RF, Finch D, Lear J, Kuhl DE. Neuronal response of the hippocampal formation to injury: blood flow, glucose metabolism, and protein synthesis. Experimental Neurology. 79: 329-46. PMID 6822267 DOI: 10.1016/0014-4886(83)90217-0 |
0.127 |
|
| 2008 |
Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 49: 63-73. PMID 19087119 DOI: 10.1111/j.1528-1167.2008.01928.x |
0.122 |
|
| 1988 |
Morin AM, Dwyer BE, Fujikawa DG, Wasterlain CG. Low [3H]cytochalasin B binding in the cerebral cortex of newborn rat. Journal of Neurochemistry. 51: 206-11. PMID 3379403 |
0.12 |
|
| 2006 |
Niquet J, Seo DW, Allen SG, Wasterlain CG. Hypoxia in presence of blockers of excitotoxicity induces a caspase-dependent neuronal necrosis. Neuroscience. 141: 77-86. PMID 16697116 DOI: 10.1016/j.neuroscience.2006.03.073 |
0.119 |
|
| 1989 |
Bronstein J, Wasterlain CG, Lasher R, Farber DB. Dark-induced changes in activity and compartmentalization of retinal calmodulin kinase in the rat. Brain Research. 495: 83-8. PMID 2550112 DOI: 10.1016/0006-8993(89)91220-1 |
0.118 |
|
| 2001 |
Thompson KW, Wasterlain CG. Urethane anesthesia produces selective damage in the piriform cortex of the developing brain. Brain Research. Developmental Brain Research. 130: 167-71. PMID 11675119 DOI: 10.1016/S0165-3806(01)00228-0 |
0.117 |
|
| 1995 |
Shirasaka Y, Wasterlain CG. The effect of urethane anesthesia on evoked potentials in dentate gyrus. European Journal of Pharmacology. 282: 11-7. PMID 7498264 DOI: 10.1016/0014-2999(95)00244-F |
0.117 |
|
| 1996 |
Penix LP, Thompson KW, Wasterlain CG. Selective vulnerability to perforant path stimulation: role of NMDA and non-NMDA receptors. Epilepsy Research. Supplement. 12: 63-73. PMID 9302504 |
0.116 |
|
| 2009 |
Pitkänen A, Wasterlain CC. Commentary: translation of laboratory findings to clinic in the treatment of status epilepticus--a mission impossible? Epilepsia. 50: 1834-5. PMID 20831523 DOI: 10.1111/j.1528-1167.2009.02084.x |
0.113 |
|
| 1985 |
Wasterlain CG, Fairchild MD. Transfer between chemical and electrical kindling in the septal-hippocampal system. Brain Research. 331: 261-6. PMID 3986569 DOI: 10.1016/0006-8993(85)91551-3 |
0.112 |
|
| 2005 |
Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 7724-33. PMID 16120773 DOI: 10.1523/JNEUROSCI.4944-04.2005 |
0.111 |
|
| 1982 |
Farber D, Wasterlain CG. Diazepam inhibits kindling and calcium- and calmodulin-stimulated phosphorylation of synaptic membrane proteins Annals of Neurology. 12: No. P46. |
0.111 |
|
| 2005 |
Niquet J, Liu H, Wasterlain CG. Programmed neuronal necrosis and status epilepticus. Epilepsia. 46: 43-8. PMID 15987252 DOI: 10.1111/j.1528-1167.2005.01025.x |
0.11 |
|
| 1981 |
Morin AM, Tanaka IA, Wasterlain CG. Norharman inhibition of [3H]diazepam binding in mouse brain. Life Sciences. 28: 2257-63. PMID 6265726 DOI: 10.1016/0024-3205(81)90578-6 |
0.11 |
|
| 2005 |
Naylor DE, Wasterlain CG. GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation. Epilepsia. 46: 142-7. PMID 15987269 DOI: 10.1111/j.1528-1167.2005.01022.x |
0.11 |
|
| 1994 |
Truong DD, Matsumoto RR, Schwartz PH, Hussong MJ, Wasterlain CG. Novel rat cardiac arrest model of posthypoxic myoclonus. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 201-6. PMID 8196684 DOI: 10.1002/mds.870090214 |
0.109 |
|
| 1980 |
Fando JL, Wasterlain CG. A simple reproducible cell-free system for measuring brain protein synthesis. Neurochemical Research. 5: 197-207. PMID 7366799 DOI: 10.1007/BF00964332 |
0.108 |
|
| 1993 |
Schwartz PH, Wasterlain CG. Determination of serum and brain concentrations of neuroprotective and non-neuroprotective doses of MK-801. Journal of the Neurological Sciences. 115: 26-31. PMID 8468589 DOI: 10.1016/0022-510X(93)90063-5 |
0.108 |
|
| 1994 |
Akira T, Henry D, Wasterlain CG. Nitric oxide mediates the sustained opening of NMDA receptor-gated ionic channels which follows transient excitotoxic exposure in hippocampal slices. Brain Research. 652: 190-4. PMID 7953729 DOI: 10.1016/0006-8993(94)90226-7 |
0.107 |
|
| 1980 |
Morin AM, Wasterlain CG. The binding of 3H-isoguvacine to mouse brain synaptic membranes. Life Sciences. 26: 1239-45. PMID 7392797 DOI: 10.1016/0024-3205(80)90069-7 |
0.107 |
|
| 1975 |
Wasterlain CG. Effects of transmitter agonists and antagonists of brain DNA synthesis. Transactions of the American Neurological Association. 100: 91-5. PMID 1226648 |
0.106 |
|
| 1995 |
Schweitzer ES, Sanderson MJ, Wasterlain CG. Inhibition of regulated catecholamine secretion from PC12 cells by the Ca2+/calmodulin kinase II inhibitor KN-62. Journal of Cell Science. 108: 2619-28. PMID 7593303 |
0.105 |
|
| 1999 |
Katsumori H, Baldwin RA, Wasterlain CG. Reverse transport of glutamate during depolarization in immature hippocampal slices. Brain Research. 819: 160-4. PMID 10082873 DOI: 10.1016/S0006-8993(98)01352-3 |
0.105 |
|
| 1990 |
Hattori H, Wasterlain CG. Excitatory amino acids in the developing brain: ontogeny, plasticity, and excitotoxicity. Pediatric Neurology. 6: 219-28. PMID 2169749 DOI: 10.1016/0887-8994(90)90111-D |
0.105 |
|
| 1993 |
Wasterlain CG, Baxter CF, Baldwin RA. GABA metabolism in the substantia nigra, cortex, and hippocampus during status epilepticus. Neurochemical Research. 18: 527-32. PMID 8474571 DOI: 10.1007/BF00967257 |
0.104 |
|
| 2023 |
Engel J, Moshé SL, Nehlig A, Fujikawa DG, Sankar R, Naylor DE, Mazarati AM, Wasterlain CG. Introduction to the Special Issue Status Epilepticus: Neuronal injury, Plasticity and Therapies: Celebrating the Legacy of Dr. Claude G. Wasterlain. Epilepsia Open. PMID 36929725 DOI: 10.1002/epi4.12724 |
0.103 |
|
| 1986 |
Bronstein JM, Farber DB, Wasterlain CG. Autophosphorylation of calmodulin kinase II: functional aspects. Febs Letters. 196: 135-8. PMID 3002861 DOI: 10.1016/0014-5793(86)80228-9 |
0.1 |
|
| 1991 |
Schwartz PH, Wasterlain CG. Cardiac arrest and resuscitation alters the pharmacokinetics of MK-801 in the rat. Research Communications in Chemical Pathology and Pharmacology. 73: 181-95. PMID 1784834 |
0.1 |
|
| 1979 |
Painter MJ, Pippenger C, Wasterlain C. Brain tissue levels of phenytoin and phenobarbital in neonates Neurology. 29: 542-543. |
0.099 |
|
| 1989 |
Fujikawa DG, Dwyer BE, Lake RR, Wasterlain CG. Local cerebral glucose utilization during status epilepticus in newborn primates. The American Journal of Physiology. 256: C1160-7. PMID 2735393 |
0.098 |
|
| 1974 |
Wasterlain CG. Brain ribosomes in intracranial hypertension. Journal of Neurochemistry. 23: 253-9. PMID 4850821 |
0.098 |
|
| 1980 |
Dwyer B, Wasterlain CG. Regulation of the first step of the initiation of brain protein synthesis by guanosine diphosphate. Journal of Neurochemistry. 34: 1639-47. PMID 7381490 |
0.097 |
|
| 1988 |
Fairchild MD, Parsons JE, Wasterlain CG, Rinaldi PC, Wallis RA. A hypoxic injury potential in the hippocampal slice. Brain Research. 453: 357-61. PMID 3401774 DOI: 10.1016/0006-8993(88)90178-3 |
0.097 |
|
| 2003 |
Niquet J, Baldwin RA, Allen SG, Fujikawa DG, Wasterlain CG. Hypoxic neuronal necrosis: protein synthesis-independent activation of a cell death program. Proceedings of the National Academy of Sciences of the United States of America. 100: 2825-30. PMID 12606726 DOI: 10.1073/pnas.0530113100 |
0.095 |
|
| 1975 |
Kutt H, Solomon G, Wasterlain C, Peterson H, Louis S, Carruthers R. Carbamazepine in difficult to control epileptic out-patients. Acta Neurologica Scandinavica. Supplementum. 60: 27-32. PMID 811074 |
0.094 |
|
| 1989 |
Baxter CF, Parsons JE, Oh CC, Wasterlain CG, Baldwin RA. Changes of amino acid gradients in brain tissues induced by microwave irradiation and other means. Neurochemical Research. 14: 909-13. PMID 2594149 DOI: 10.1007/BF00964823 |
0.093 |
|
| 1968 |
Wasterlain CG, Torack RM. Cerebral edema in water intoxication. II. An ultrastructural study. Archives of Neurology. 19: 79-87. PMID 4877798 DOI: 10.1001/Archneur.1968.00480010097008 |
0.092 |
|
| 1979 |
Wasterlain CG, Morin AM, Jonec V, Billawalla T. Kindling with blockers of inhibitory synapses Neurology. 29: 582. |
0.091 |
|
| 1981 |
Wasterlain CG, Dwyer B, Fando J, Lieber C. Inhibition of brain protein synthesis by chronic ethanol in the absence of malnutrition Substance and Alcohol Actions/Misuse. 2: 202. |
0.089 |
|
| 1988 |
Bronstein JM, Wasterlain CG, Farber DB. A retinal calmodulin-dependent kinase: calcium/calmodulin-stimulated and -inhibited states. Journal of Neurochemistry. 50: 1438-46. PMID 3361303 DOI: 10.1111/J.1471-4159.1988.Tb03028.X |
0.088 |
|
| 1992 |
Wallis RA, Panizzon K, Wasterlain CG. Inhibition of nitric oxide synthase protects against hypoxic neuronal injury. Neuroreport. 3: 645-8. PMID 1384768 |
0.087 |
|
| 1982 |
Dwyer BE, Donatoni P, Wasterlain CG. A quantitative autoradiographic method for the measurement of local rates of brain protein synthesis. Neurochemical Research. 7: 563-76. PMID 7121713 DOI: 10.1007/BF00965123 |
0.087 |
|
| 2000 |
Rogawski MA, Wasterlain CG, Mazarati AM. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor". Epilepsia. 41: 918-9. PMID 10897169 DOI: 10.1111/J.1528-1157.2000.Tb00265.X |
0.084 |
|
| 1988 |
Bronstein JM, Wasterlain CG, Bok D, Lasher R, Farber DB. Localization of retinal calmodulin kinase. Experimental Eye Research. 47: 391-402. PMID 2846334 DOI: 10.1016/0014-4835(88)90050-4 |
0.083 |
|
| 1982 |
Wasterlain CG, Morin AM, Jonec V. Kindling: a pharmacological approach. Electroencephalography and Clinical Neurophysiology. Supplement. 36: 264-73. PMID 6962022 |
0.083 |
|
| 1982 |
Dwyer BE, Donatoni P, Wasterlain CG. Measurement of local rates of brain protein synthesis by quantitative autoradiography: validation with L-[3H]valine. Neurochemical Research. 7: 1507-14. PMID 7170064 DOI: 10.1007/BF00965093 |
0.078 |
|
| 2010 |
Niquet J, Lopez-Meraz ML, Wasterlain CG. Programmed necrosis after status epilepticus Epilepsia. 51: 36. DOI: 10.1111/j.1528-1167.2010.02822.x |
0.076 |
|
| 1982 |
Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. Current concepts in neurology: management of status epilepticus. The New England Journal of Medicine. 306: 1337-40. PMID 7070459 DOI: 10.1056/NEJM198206033062205 |
0.075 |
|
| 2006 |
Chen JW, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. The Lancet. Neurology. 5: 246-56. PMID 16488380 DOI: 10.1016/S1474-4422(06)70374-X |
0.074 |
|
| 1983 |
Metter EJ, Riege WH, Hanson WR, Kuhl DE, Phelps ME, Squire LR, Wasterlain CG, Benson DF. Comparison of metabolic rates, language, and memory in subcortical aphasias. Brain and Language. 19: 33-47. PMID 6602643 DOI: 10.1016/0093-934X(83)90054-8 |
0.071 |
|
| 2009 |
Seo DW, Lopez-Meraz ML, Allen S, Wasterlain CG, Niquet J. Contribution of a mitochondrial pathway to excitotoxic neuronal necrosis. Journal of Neuroscience Research. 87: 2087-94. PMID 19235896 DOI: 10.1002/jnr.22035 |
0.07 |
|
| 1994 |
Akira T, Henry D, Baldwin RA, Wasterlain CG. Nitric oxide participates in excitotoxic mechanisms induced by chemical hypoxia. Brain Research. 645: 285-90. PMID 7520342 DOI: 10.1016/0006-8993(94)91662-4 |
0.066 |
|
| 1975 |
Sweet RD, McDowell FH, Wasterlain CG, Stern PH. Treatment of "on-off effect" with a dopa decarboxylase inhibitor. Archives of Neurology. 32: 560-3. PMID 1156214 DOI: 10.1001/archneur.1975.00490500080010 |
0.063 |
|
| 1968 |
Wasterlain CG, Posner JB. Cerebral edema in water intoxication. I. Clinical and chemical observations. Archives of Neurology. 19: 71-8. PMID 5676922 |
0.063 |
|
| 2006 |
Niquet J, Seo DW, Wasterlain CG. Mitochondrial pathways of neuronal necrosis. Biochemical Society Transactions. 34: 1347-51. PMID 17073816 DOI: 10.1042/BST0341347 |
0.06 |
|
| 1971 |
Wasterlain CG. Are there two types of post-traumatic retrograde amnesia? European Neurology. 5: 225-8. PMID 5126567 |
0.06 |
|
| 2004 |
Niquet J, Allen SG, Baldwin RA, Wasterlain CG. Evidence of caspase-3 activation in hyposmotic stress-induced necrosis. Neuroscience Letters. 356: 225-7. PMID 15036635 DOI: 10.1016/j.neulet.2003.11.063 |
0.059 |
|
| 1981 |
Metter EJ, Wasterlain CG, Kuhl DE, Hanson WR, Phelps ME. FDG positron emission computed tomography in a study of aphasia. Annals of Neurology. 10: 173-83. PMID 6169302 DOI: 10.1002/Ana.410100208 |
0.055 |
|
| 1993 |
Wallis RA, Panizzon KL, Henry D, Wasterlain CG. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. Neuroreport. 5: 245-8. PMID 8298082 |
0.053 |
|
| 1978 |
Morin AM, Wasterlain CG. Stoichiometry of GABA and CO2 formation in glutamate decarboxylase assays: alteration by an impurity L-U-[14C] glutamate. Journal of Neurochemistry. 31: 371-3. PMID 671034 |
0.052 |
|
| 1987 |
Steinman JL, Fujikawa DG, Wasterlain CG, Cherkin A, Morley JE. The effects of adrenergic, opioid and pancreatic polypeptidergic compounds on feeding and other behaviors in neonatal leghorn chicks. Peptides. 8: 585-92. PMID 2888097 DOI: 10.1016/0196-9781(87)90029-5 |
0.037 |
|
| 1994 |
Thompson KW, Wasterlain CG. Re: Dextromethorphan Neurology. 44: 583. |
0.035 |
|
| 2005 |
Wasterlain CG, Mazarati A. Nervous system Drug Discovery Today: Disease Mechanisms. 2: 391-392. DOI: 10.1016/j.ddmec.2005.11.014 |
0.034 |
|
| 1970 |
Wasterlain CG. CO2 anaesthesia inhibits RNA synthesis. Brain Research. 21: 452-4. PMID 5456737 |
0.023 |
|
| 1965 |
WASTERLAIN CG. RESORPTION PATHWAYS OF METHIONINE S35 FROM CSF: AN AUTORADIOGRAPHIC STUDY. Archives of Neurology. 13: 77-83. PMID 14314278 |
0.022 |
|
| 2001 |
Liebeskind DS, Ostrzega N, Wasterlain CG, Buttner EA. Neurologic manifestations of disseminated infection with Mycobacterium abscessus. Neurology. 56: 810-3. PMID 11274327 |
0.021 |
|
| 1974 |
Sweet RD, Wasterlain C, McDowell FH. Piribedil--an oral dopamine agonist for treatment of Parkinson's disease. Transactions of the American Neurological Association. 99: 258-60. PMID 4463553 |
0.02 |
|
| 1968 |
Wasterlain CG. Subacute sclerosing panencephalitis. The New England Journal of Medicine. 278: 966. PMID 5644567 |
0.016 |
|
| 1963 |
WASTERLAIN C. [Study of resorption and secretion of cerebrospinal fluid by autoradiography at low temperature]. Comptes Rendus Des Sã©Ances De La Sociã©Tã© De Biologie Et De Ses Filiales. 157: 413-6. PMID 13999066 |
0.014 |
|
| 1985 |
Wasterlain C. [Home childbirth today]. Flash-Informations. 9-11. PMID 3852754 |
0.014 |
|
| 1999 |
Sankar R, Wasterlain CG. Is the devil we know the lesser of two evils? Vigabatrin and visual fields. Neurology. 52: 1537-8. PMID 10331674 DOI: 10.1212/WNL.52.8.1537 |
0.01 |
|
| 1994 |
Friedlander AH, Manesh F, Wasterlain CG. Prevalence of detectable carotid artery calcifications on panoramic radiographs of recent stroke victims. Oral Surgery, Oral Medicine, and Oral Pathology. 77: 669-73. PMID 8065736 DOI: 10.1016/0030-4220(94)90332-8 |
0.01 |
|
| 1979 |
Metter EJ, Hanson W, Wasterlain CG, Kuhl DE, Phelps M. Usefulness of [18F]-deoxyglucose local metabolic rates in aphasia. Transactions of the American Neurological Association. 104: 200-3. PMID 317936 |
0.01 |
|
| 1974 |
Sweet RD, Wasterlain CG, McDowell FH. Piribedil, a dopamine agonist, in Parkinson's disease. Clinical Pharmacology and Therapeutics. 16: 1077-82. PMID 4611465 |
0.01 |
|
| 1962 |
WASTERLAIN C. [Resorption of the cerebrospinal fluid]. Acta Neurologica Belgica. 62: 201-12. PMID 14005151 |
0.01 |
|
| Hide low-probability matches. |